Press release content from Business Wire. The AP news staff was not involved in its creation.
Extended FEops HEARTguide™ Offering Now Available
December 18, 2020 GMT
GENT, Belgium--(BUSINESS WIRE)--Dec 18, 2020--
FEops, a digital health leader in personalized predictive planning for structural heart interventions, is proud to announce the new release of
FEops HEARTguide TM. This includes the full range of the Boston Scientific WATCHMAN FLX™ devices, enhanced visualization for the prediction of paravalvular leak (PVL) and conduction abnormalities (CA) for the transcatheter aortic valve implantation (TAVI) workflow. This product will also offer a faster turnaround for the left atrial appendage occlusion (LAAo) workflow.